chr3-155084189-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_007289.4(MME):āc.22A>Gā(p.Met8Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0231 in 1,613,950 control chromosomes in the GnomAD database, including 525 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.017 ( 33 hom., cov: 33)
Exomes š: 0.024 ( 492 hom. )
Consequence
MME
NM_007289.4 missense
NM_007289.4 missense
Scores
9
9
Clinical Significance
Conservation
PhyloP100: 3.55
Genes affected
MME (HGNC:7154): (membrane metalloendopeptidase) The protein encoded by this gene is a type II transmembrane glycoprotein and a common acute lymphocytic leukemia antigen that is an important cell surface marker in the diagnosis of human acute lymphocytic leukemia (ALL). The encoded protein is present on leukemic cells of pre-B phenotype, which represent 85% of cases of ALL. This protein is not restricted to leukemic cells, however, and is found on a variety of normal tissues. The protein is a neutral endopeptidase that cleaves peptides at the amino side of hydrophobic residues and inactivates several peptide hormones including glucagon, enkephalins, substance P, neurotensin, oxytocin, and bradykinin. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.007651925).
BP6
Variant 3-155084189-A-G is Benign according to our data. Variant chr3-155084189-A-G is described in ClinVar as [Benign]. Clinvar id is 1221640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-155084189-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0166 (2525/152306) while in subpopulation NFE AF= 0.0266 (1810/68028). AF 95% confidence interval is 0.0256. There are 33 homozygotes in gnomad4. There are 1190 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 33 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MME | NM_007289.4 | c.22A>G | p.Met8Val | missense_variant | 2/23 | ENST00000360490.7 | NP_009220.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MME | ENST00000360490.7 | c.22A>G | p.Met8Val | missense_variant | 2/23 | 1 | NM_007289.4 | ENSP00000353679.2 |
Frequencies
GnomAD3 genomes AF: 0.0166 AC: 2525AN: 152188Hom.: 33 Cov.: 33
GnomAD3 genomes
AF:
AC:
2525
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0164 AC: 4119AN: 251436Hom.: 48 AF XY: 0.0171 AC XY: 2324AN XY: 135896
GnomAD3 exomes
AF:
AC:
4119
AN:
251436
Hom.:
AF XY:
AC XY:
2324
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0237 AC: 34696AN: 1461644Hom.: 492 Cov.: 31 AF XY: 0.0235 AC XY: 17116AN XY: 727140
GnomAD4 exome
AF:
AC:
34696
AN:
1461644
Hom.:
Cov.:
31
AF XY:
AC XY:
17116
AN XY:
727140
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0166 AC: 2525AN: 152306Hom.: 33 Cov.: 33 AF XY: 0.0160 AC XY: 1190AN XY: 74490
GnomAD4 genome
AF:
AC:
2525
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
1190
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
91
ALSPAC
AF:
AC:
107
ESP6500AA
AF:
AC:
26
ESP6500EA
AF:
AC:
237
ExAC
AF:
AC:
1990
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 19, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
MME-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.;T;T;T;T;.;T;.;T;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;D;D;.;.;.;.;D;D;.;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;.;L;.;.;.;L;L;L;.;.;.;.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N;.;D;N;N;N;N;N;D;N;.
REVEL
Uncertain
Sift
Uncertain
D;.;D;D;.;D;D;D;D;D;T;.;T;.
Sift4G
Benign
T;D;T;T;D;D;T;T;T;T;D;.;T;T
Polyphen
P;.;P;.;.;.;P;P;P;.;.;.;.;P
Vest4
MPC
0.12
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at